Product
Currency:CNY
2024/FY
Stock NameRevenueRatio
细胞和基因治疗CDMO业务134.94M54.38%
细胞和基因治疗CRO业务85.82M34.58%
生物制剂、试剂及其他23.94M9.65%
Other business3.13M1.26%
再生医学服务业务316.96K0.13%
Industry
Currency:CNY
2024/FY
Stock NameRevenueRatio
Biological medicine245.02M98.74%
Other business3.13M1.26%
Region
Currency:CNY
2024/FY
Stock NameRevenueRatio
East China region147.55M59.46%
North China region39.26M15.82%
South China region26.06M10.50%
Other areas of the territory21.7M8.74%
Southwest region8.84M3.56%
Other business3.13M1.26%
Overseas1.62M0.65%
View all